Reviewing the Modern Therapeutical Options and the Outcomes of Sacubitril/Valsartan in Heart Failure

Sacubitril/valsartan (S/V) is a pharmaceutical strategy that increases natriuretic peptide levels by inhibiting neprilysin and regulating the renin-angiotensin-aldosterone pathway, blocking AT1 receptors. The data for this innovative medication are mainly based on the PARADIGM-HF study, which includ...

Descripción completa

Detalles Bibliográficos
Autores principales: Iovanovici, Diana-Carina, Bungau, Simona Gabriela, Vesa, Cosmin Mihai, Moisi, Madalina, Babes, Elena Emilia, Tit, Delia Mirela, Horvath, Tunde, Behl, Tapan, Rus, Marius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570001/
https://www.ncbi.nlm.nih.gov/pubmed/36232632
http://dx.doi.org/10.3390/ijms231911336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570001/
https://www.ncbi.nlm.nih.gov/pubmed/36232632
http://dx.doi.org/10.3390/ijms231911336

Ejemplares similares